|

Zytiga® (Abiraterone Acetate) Clinical Trials

1 actively recruiting trial

Also known as: abiraterone acetate

Pipeline

Phase 2: 1

Top Sponsors

  • Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic1

Indications

  • Prostatic Neoplasms, Castration-Resistant1
  • Cancer1

Other1 trial

Fractionated Stereotactic Radiotherapy Plus Second-generation Antiandrogen for Oligometastatic Castration-resistant Prostate Cancer Patients.
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.